Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 8 shares (to pay taxes)
  2. 4 Planned sale Head of Development sold 517 shares at $133.55 ($69,045)
  3. 4 Planned sale Head of Global Product Strat. sold 2,223 shares at $135.00 ($300,105)
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Director acquired 2,370 shares (grant or award)
  6. 4 Grant or award Director acquired 2,370 shares (grant or award)
  7. 4 Grant or award Director acquired 2,370 shares (grant or award)
  8. 4 Grant or award Director acquired 2,370 shares (grant or award)
  9. 4 Grant or award Director acquired 2,370 shares (grant or award)
  10. 4 Grant or award Director acquired 2,370 shares (grant or award)
  11. 4 Grant or award Director acquired 2,370 shares (grant or award)
  12. 4 Grant or award Director acquired 2,370 shares (grant or award)
  13. 4 Grant or award Director acquired 3,160 shares (grant or award)
  14. 4 Planned sale Head of Development sold 3,806 shares at $126.25 ($480,508)
  15. 4 Shares withheld for taxes Head of Corporate Development gave up 454 shares (to pay taxes)
  16. 4 Open-market buy Director bought 1,235 shares at $122.72 ($151,559)
  17. 4 Derivatives Options or other derivatives
  18. 4 Planned sale Director sold 8,760 shares at $150.02 ($1,314,142)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Shares withheld for taxes Head of Development gave up 357 shares (to pay taxes)

Page 3 of 86 · 1,714 filings